- Report
- September 2025
- 383 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 480 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 279 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 116 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 393 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 375 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 287 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 278 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 383 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 478 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 287 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 469 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 385 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 280 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 280 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 290 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 297 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 364 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 294 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 385 Pages
Global
From €5146EUR$5,850USD£4,465GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more